Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report)’s stock price fell 11.9% during trading on Monday . The company traded as low as $0.21 and last traded at $0.28. 598 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 2,557 shares. The stock had previously closed at $0.3180.
Longevity Health Stock Down 11.9%
The company has a 50 day simple moving average of $0.26 and a 200-day simple moving average of $0.30. The stock has a market cap of $498,960.00, a price-to-earnings ratio of -0.07 and a beta of 0.40.
Longevity Health Company Profile
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Recommended Stories
- Five stocks we like better than Longevity Health
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
